Comparison between various fracture risk assessment tools W. D. LeslieL. M. Lix Review 25 June 2013 Pages: 1 - 21
Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review S. NayakD. L. EdwardsS. L. Greenspan Review 09 October 2013 Pages: 23 - 49
A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures L. SiT. M. WinzenbergA. J. Palmer Review 24 October 2013 Pages: 51 - 60
FRAX provides robust fracture prediction regardless of socioeconomic status S. L. BrennanW. D. LeslieJ. A. Kanis Original Article 05 November 2013 Pages: 61 - 69
The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease S. A. JamalS. L. WestT. L. Nickolas Original Article 11 October 2013 Pages: 71 - 76
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial D. Prieto-AlhambraA. JudgeM. K. Javaid Original Article 28 June 2013 Pages: 77 - 83
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study C. L. GregsonE. M. Dennisonfor the GLOW Investigators Original Article 25 July 2013 Pages: 85 - 95
Association between hypertension and fragility fracture: a longitudinal study S. YangN. D. NguyenT. V. Nguyen Original Article 27 July 2013 Pages: 97 - 103
Association between use of benzodiazepines and risk of fractures: a meta-analysis D. XingX. L. MaY. Chen Original Article 07 September 2013 Pages: 105 - 120
β-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects K. A. ToulisK. HemmingJ. P. Bilezikian Original Article 10 October 2013 Pages: 121 - 129
Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS Sweden C. LewerinH. Nilsson-EhleD. Mellström Original Article 16 October 2013 Pages: 131 - 140
Coffee, tea, and the risk of hip fracture: a meta-analysis J. ShengX. QuK. Dai Original Article 06 November 2013 Pages: 141 - 150
Fracture risk following bariatric surgery: a population-based study K. M. NakamuraE. G. C. HaglindK. A. Kennel Original Article 03 August 2013 Pages: 151 - 158
Incidence and risk factors for hip fractures in dialysis patients M. MaravicA. OstertagM. Cohen-Solal Original Article 09 July 2013 Pages: 159 - 165
Gender-specific hip fracture risk in community-dwelling and institutionalized seniors age 65 years and older M. FinsterwaldE. SidelnikovH. A. Bischoff-Ferrari Original Article 18 October 2013 Pages: 167 - 176
Exploring the determinants of fracture risk among individuals with spinal cord injury D. LalaB. C. CravenL. M. Giangregorio Original Article 28 June 2013 Pages: 177 - 185
Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults D. ScottA. HayesG. Jones Original Article 26 June 2013 Pages: 187 - 193
Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation D. A. EekmanM. M. ter WeeW. F. Lems Original Article 27 September 2013 Pages: 195 - 204
Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces R. G. CrillyM. KloseckJ. Gilliland Original Article 02 August 2013 Pages: 205 - 210
Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989–2008 K. SiggeirsdottirT. AspelundG. Sigurdsson Original Article 02 July 2013 Pages: 211 - 219
Erratum to: Epidemiology of fractures in Iceland and secular trends in major osteoporotic fractures 1989–2008 K. SiggeirsdottirT. AspelundG. Sigurdsson Erratum 22 October 2013 Pages: 221 - 221
Effect of increased fruit and vegetable consumption on bone turnover in older adults: a randomised controlled trial C. E. NevilleI. S. YoungJ. V. Woodside Original Article 29 May 2013 Pages: 223 - 233
Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures H. JohanssonA. OdénJ. A. Kanis Original Article 22 August 2013 Pages: 235 - 241
Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range K. NassarS. PaternotteK. Briot Original Article 01 October 2013 Pages: 243 - 249
Distribution of bone density and cortical thickness in the proximal femur and their association with hip fracture in postmenopausal women: a quantitative computed tomography study L. YangW. J. M. UdallR. Eastell Original Article 30 May 2013 Pages: 251 - 263
Physical activity as determinant of femoral neck strength relative to load in adult women: findings from the hip strength across the menopause transition study T. MoriS. IshiiA. S. Karlamangla Original Article 28 June 2013 Pages: 265 - 272
Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women? S. L. BrennanW. D. LeslieL. M. Lix Original Article 02 August 2013 Pages: 273 - 279
Non-pharmacological strategies used by patients at high risk for future fracture to manage fracture risk—a qualitative study J. E. M. SaleM. A. GignacV. Elliot-Gibson Original Article 06 June 2013 Pages: 281 - 288
Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy’s fracture clinic screening program D. E. BeatonS. DyerThe Osteoporosis Fracture Clinic Screening Program Evaluation Team Original Article 21 June 2013 Pages: 289 - 296
The Auckland calcium study: 5-year post-trial follow-up L. T. RadfordM. J. BollandI. R. Reid Original Article 10 October 2013 Pages: 297 - 304
A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity? A. D. WoodK. R. SecombesH. M. Macdonald Original Article 28 August 2013 Pages: 305 - 315
Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass J. ZhangE. DelzellK. G. Saag Original Article 28 August 2013 Pages: 317 - 324
Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm K. KimA. SvedbomJ. A. Kanis Original Article 10 October 2013 Pages: 325 - 337
The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis P. HadjiD. FelsenbergA. Kurth Original Article 03 October 2013 Pages: 339 - 347
Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies P. D. MillerR. R. ReckerD. Masanauskaite Original Article 18 October 2013 Pages: 349 - 357
Effect of ibandronate on spontaneous osteonecrosis of the knee: a randomized, double-blind, placebo-controlled trial C. MeierC. KraenzlinM. E. Kraenzlin Original Article 22 November 2013 Pages: 359 - 366
Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis—a double-blind, randomized, dose-finding study T. NakamuraM. ShirakiS. Uchida Original Article 29 May 2013 Pages: 367 - 376
An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide R. NiimiT. KonoA. Sudo Original Article 29 June 2013 Pages: 377 - 384
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial C. KlopF. de VriesM. L. Bouvy Original Article Open access 13 November 2013 Pages: 385 - 392
Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab A. NeuprezS. CosteJ. Y. Reginster Case Report Open access 09 July 2013 Pages: 393 - 395